fda decision: gedatolisib by celcuity inc. (on 2026-01-01)
Full Approval
fda decision: gedatolisib by celcuity inc. (on 2026-01-01). Best Yes near 81¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 81¢ · Best No: 25¢ · 1 platform
- Kalshi: Yes 81¢ / No 25¢
LIVE
Full Approval
Volume
$846
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Aug 1, 2026
~46 days left
Category
Economics
Yes
81¢
Kalshi
No
25¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Full Approval before Aug 1, 2026, the market resolves to Yes.
Market Details
ResolutionResolves Aug 1, 2026
Time Left46 days
Status● Active
CategoryEconomics
Yes
81¢
Kalshi
Payout 1.2x
No
25¢
Kalshi
Payout 4.0x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In